middle.news
Imagion Biosystems Advances HER2 Breast Cancer Imaging with Positive WSU Results
9:42am on Wednesday 5th of November, 2025 AEDT
•
Healthcare
Read Story
Imagion Biosystems Advances HER2 Breast Cancer Imaging with Positive WSU Results
9:42am on Wednesday 5th of November, 2025 AEDT
Key Points
Positive Wayne State University results on MagSense® HER2 imaging agent dosage
Lower dose likely detectable, enhancing safety and patient experience
Optimised MRI sequences to improve imaging quality for Phase 2 trial
FDA IND submission for Phase 2 HER2 breast cancer trial on track for Q4 2025
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
IMAGION BIOSYSTEMS (ASX:IBX)
OPEN ARTICLE